-
-
-
-
-
-
-
UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases
-
-
-
-
-
-
-
Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program
-
-
-
-
-
-
-
Ra Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

